Amyloid-β(1-15/16) as a marker for γ-secretase inhibition in Alzheimer's disease.
Portelius E, Zetterberg H, Dean RA, Marcil A, Bourgeois P, Nutu M, Andreasson U, Siemers E, Mawuenyega KG, Sigurdson WC, May PC, Paul SM, Holtzman DM, Blennow K, Bateman RJ.
Portelius E, et al. Among authors: holtzman dm.
J Alzheimers Dis. 2012;31(2):335-41. doi: 10.3233/JAD-2012-120508.
J Alzheimers Dis. 2012.
PMID: 22531418
Free PMC article.
Clinical Trial.